Annual Registration Fees Proposed For Firms Across FDA’s Regulatory Range
This article was originally published in The Tan Sheet
Executive Summary
Leading House Democrats plan to expedite hearings on draft legislation to comprehensively strengthen FDA's global safety oversight for food, drug and cosmetic products, with a Health Subcommittee hearing scheduled April 24
You may also be interested in...
FDA Right On Risk Approach, Slow On Food Protection Progress – GAO
The Government Accountability Office cites significant cost savings in its endorsement of FDA's risk-based approach to import safety inspections, but says the agency has yet to deliver on plans for tightening its protection of the U.S. food supply
FDA Right On Risk Approach, Slow On Food Protection Progress – GAO
The Government Accountability Office cites significant cost savings in its endorsement of FDA's risk-based approach to import safety inspections, but says the agency has yet to deliver on plans for tightening its protection of the U.S. food supply
FDA Right On Risk Approach, Slow On Food Protection Progress – GAO
The Government Accountability Office cites significant cost savings in its endorsement of FDA's risk-based approach to import safety inspections, but says the agency has yet to deliver on plans for tightening its protection of the U.S. food supply